Page last updated: 2024-09-03

tak 044 and tcv 309

tak 044 has been researched along with tcv 309 in 1 studies

Compound Research Comparison

Studies (tak 044)	Trials (tak 044)	Recent Studies (post-2010) (tak 044)	Studies (tcv 309)	Trials (tcv 309)	Recent Studies (post-2010) (tcv 309)
105	8	2	68	2	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carboni, GL; Hillinger, S; Schmid, RA; Schneiter, D; Stammberger, U; Weder, W	1

Other Studies

1 other study(ies) available for tak 044 and tcv 309

Article	Year
Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:9 Topics: Animals; Drug Therapy, Combination; Endothelin Receptor Antagonists; Isoquinolines; Lipid Peroxidation; Lung; Lung Transplantation; Male; Oxygen; Peptides, Cyclic; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred F344; Reperfusion Injury; Tetrahydroisoquinolines; Thiobarbituric Acid Reactive Substances	1999

Article

Year

Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:9

Topics: Animals; Drug Therapy, Combination; Endothelin Receptor Antagonists; Isoquinolines; Lipid Peroxidation; Lung; Lung Transplantation; Male; Oxygen; Peptides, Cyclic; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred F344; Reperfusion Injury; Tetrahydroisoquinolines; Thiobarbituric Acid Reactive Substances

1999